Medicine · 2026
The impact of chalazion after treatment on the morphology of the meibomian glands in children: An observational study.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jiang Jiao, Yang Xiaoge, Du Feifan, Zheng Wei, Yang Yang
Аннотация
UNLABELLED: Morphological changes in the meibomian glands following treatment of pediatric chalazion were assessed using an ocular surface analyzer, and the effects of surgical versus conservative management on gland morphology were systematically compared.
METHODS: A total of 132 children with chalazion who had achieved complete recovery after treatment were selected as the research subjects and divided into 2 groups according to different treatment methods: the surgical treatment group (52 cases) and the drug treatment group (80 cases). Meanwhile, 40 asymptomatic healthy children during the same period were selected as the control group. The degree of meibomian gland loss was calculated and scored by using the ocular surface comprehensive analyzer.
RESULT: The meibomian gland loss score in the surgical group was (0.89 ± 0.96), in the drug treatment group it was (0.78 ± 0.61), and in the control group it was (0.40 ± 0.35). There was a significant difference in the score of meibomian gland loss between the chalazion group and the control group (P <.05). However, there was no significant difference in the degree of meibomian gland loss between surgical group and the drug group (P >.05).
CONCLUSION: Chalazion can lead to meibomian gland loss, and changing the treatment method will not improve this situation. How to control the recurrence of chalazion is particularly important in preventing pediatric meibomian gland dysfunction.
METHODS: A total of 132 children with chalazion who had achieved complete recovery after treatment were selected as the research subjects and divided into 2 groups according to different treatment methods: the surgical treatment group (52 cases) and the drug treatment group (80 cases). Meanwhile, 40 asymptomatic healthy children during the same period were selected as the control group. The degree of meibomian gland loss was calculated and scored by using the ocular surface comprehensive analyzer.
RESULT: The meibomian gland loss score in the surgical group was (0.89 ± 0.96), in the drug treatment group it was (0.78 ± 0.61), and in the control group it was (0.40 ± 0.35). There was a significant difference in the score of meibomian gland loss between the chalazion group and the control group (P <.05). However, there was no significant difference in the degree of meibomian gland loss between surgical group and the drug group (P >.05).
CONCLUSION: Chalazion can lead to meibomian gland loss, and changing the treatment method will not improve this situation. How to control the recurrence of chalazion is particularly important in preventing pediatric meibomian gland dysfunction.